Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 16 |
NetGPI | no | yes: 0, no: 16 |
Related structures:
AlphaFold database: A4H7J8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 218 | 222 | PF00656 | 0.462 |
CLV_C14_Caspase3-7 | 231 | 235 | PF00656 | 0.594 |
CLV_C14_Caspase3-7 | 36 | 40 | PF00656 | 0.246 |
CLV_NRD_NRD_1 | 207 | 209 | PF00675 | 0.409 |
CLV_PCSK_SKI1_1 | 116 | 120 | PF00082 | 0.449 |
CLV_PCSK_SKI1_1 | 196 | 200 | PF00082 | 0.357 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.415 |
CLV_PCSK_SKI1_1 | 47 | 51 | PF00082 | 0.261 |
CLV_Separin_Metazoa | 87 | 91 | PF03568 | 0.306 |
DOC_CDC14_PxL_1 | 150 | 158 | PF14671 | 0.302 |
DOC_MAPK_gen_1 | 47 | 57 | PF00069 | 0.386 |
DOC_MAPK_MEF2A_6 | 121 | 129 | PF00069 | 0.338 |
DOC_MAPK_MEF2A_6 | 50 | 57 | PF00069 | 0.348 |
DOC_MAPK_NFAT4_5 | 50 | 58 | PF00069 | 0.288 |
DOC_PP1_RVXF_1 | 259 | 265 | PF00149 | 0.506 |
DOC_PP1_RVXF_1 | 45 | 52 | PF00149 | 0.462 |
DOC_PP4_FxxP_1 | 69 | 72 | PF00568 | 0.269 |
DOC_USP7_MATH_1 | 163 | 167 | PF00917 | 0.387 |
DOC_USP7_MATH_1 | 98 | 102 | PF00917 | 0.533 |
DOC_USP7_UBL2_3 | 192 | 196 | PF12436 | 0.283 |
LIG_14-3-3_CanoR_1 | 20 | 25 | PF00244 | 0.267 |
LIG_14-3-3_CanoR_1 | 208 | 214 | PF00244 | 0.329 |
LIG_14-3-3_CanoR_1 | 261 | 265 | PF00244 | 0.451 |
LIG_14-3-3_CanoR_1 | 90 | 98 | PF00244 | 0.429 |
LIG_BIR_III_4 | 221 | 225 | PF00653 | 0.415 |
LIG_BRCT_BRCA1_1 | 165 | 169 | PF00533 | 0.356 |
LIG_BRCT_BRCA1_1 | 77 | 81 | PF00533 | 0.231 |
LIG_eIF4E_1 | 170 | 176 | PF01652 | 0.283 |
LIG_FHA_1 | 122 | 128 | PF00498 | 0.422 |
LIG_FHA_1 | 21 | 27 | PF00498 | 0.326 |
LIG_FHA_1 | 214 | 220 | PF00498 | 0.318 |
LIG_FHA_1 | 266 | 272 | PF00498 | 0.569 |
LIG_FHA_1 | 294 | 300 | PF00498 | 0.628 |
LIG_FHA_2 | 34 | 40 | PF00498 | 0.262 |
LIG_FHA_2 | 94 | 100 | PF00498 | 0.420 |
LIG_LIR_Apic_2 | 148 | 154 | PF02991 | 0.374 |
LIG_LIR_Gen_1 | 197 | 206 | PF02991 | 0.434 |
LIG_LIR_Gen_1 | 304 | 310 | PF02991 | 0.517 |
LIG_LIR_Gen_1 | 78 | 89 | PF02991 | 0.255 |
LIG_LIR_LC3C_4 | 122 | 127 | PF02991 | 0.310 |
LIG_LIR_Nem_3 | 197 | 202 | PF02991 | 0.370 |
LIG_LIR_Nem_3 | 225 | 230 | PF02991 | 0.315 |
LIG_LIR_Nem_3 | 23 | 27 | PF02991 | 0.423 |
LIG_LIR_Nem_3 | 78 | 84 | PF02991 | 0.354 |
LIG_Pex14_2 | 65 | 69 | PF04695 | 0.235 |
LIG_PTB_Apo_2 | 45 | 52 | PF02174 | 0.249 |
LIG_SH2_CRK | 77 | 81 | PF00017 | 0.425 |
LIG_SH2_STAP1 | 77 | 81 | PF00017 | 0.352 |
LIG_SH2_STAT5 | 160 | 163 | PF00017 | 0.451 |
LIG_SH2_STAT5 | 170 | 173 | PF00017 | 0.352 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.440 |
LIG_SH2_STAT5 | 228 | 231 | PF00017 | 0.449 |
LIG_SH2_STAT5 | 66 | 69 | PF00017 | 0.381 |
LIG_SH2_STAT5 | 79 | 82 | PF00017 | 0.371 |
LIG_SH3_3 | 69 | 75 | PF00018 | 0.431 |
LIG_SUMO_SIM_anti_2 | 122 | 130 | PF11976 | 0.267 |
LIG_SUMO_SIM_anti_2 | 174 | 179 | PF11976 | 0.244 |
LIG_SUMO_SIM_anti_2 | 216 | 221 | PF11976 | 0.417 |
LIG_SUMO_SIM_par_1 | 122 | 130 | PF11976 | 0.390 |
LIG_SUMO_SIM_par_1 | 215 | 221 | PF11976 | 0.269 |
LIG_SUMO_SIM_par_1 | 294 | 301 | PF11976 | 0.621 |
LIG_UBA3_1 | 202 | 209 | PF00899 | 0.370 |
LIG_WRC_WIRS_1 | 128 | 133 | PF05994 | 0.455 |
MOD_CK1_1 | 31 | 37 | PF00069 | 0.496 |
MOD_CK2_1 | 289 | 295 | PF00069 | 0.588 |
MOD_CK2_1 | 93 | 99 | PF00069 | 0.515 |
MOD_GlcNHglycan | 236 | 239 | PF01048 | 0.574 |
MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.556 |
MOD_GSK3_1 | 179 | 186 | PF00069 | 0.399 |
MOD_GSK3_1 | 260 | 267 | PF00069 | 0.339 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.314 |
MOD_GSK3_1 | 289 | 296 | PF00069 | 0.599 |
MOD_N-GLC_1 | 20 | 25 | PF02516 | 0.351 |
MOD_N-GLC_1 | 250 | 255 | PF02516 | 0.342 |
MOD_N-GLC_1 | 27 | 32 | PF02516 | 0.380 |
MOD_N-GLC_2 | 108 | 110 | PF02516 | 0.381 |
MOD_NEK2_1 | 169 | 174 | PF00069 | 0.338 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.263 |
MOD_NEK2_1 | 264 | 269 | PF00069 | 0.603 |
MOD_NEK2_1 | 53 | 58 | PF00069 | 0.381 |
MOD_PIKK_1 | 250 | 256 | PF00454 | 0.322 |
MOD_PKA_1 | 208 | 214 | PF00069 | 0.443 |
MOD_PKA_2 | 207 | 213 | PF00069 | 0.304 |
MOD_PKA_2 | 260 | 266 | PF00069 | 0.314 |
MOD_Plk_1 | 121 | 127 | PF00069 | 0.452 |
MOD_Plk_1 | 20 | 26 | PF00069 | 0.397 |
MOD_Plk_1 | 293 | 299 | PF00069 | 0.726 |
MOD_Plk_2-3 | 134 | 140 | PF00069 | 0.405 |
MOD_Plk_4 | 121 | 127 | PF00069 | 0.419 |
MOD_Plk_4 | 145 | 151 | PF00069 | 0.297 |
MOD_Plk_4 | 171 | 177 | PF00069 | 0.453 |
MOD_Plk_4 | 33 | 39 | PF00069 | 0.365 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.358 |
MOD_SUMO_rev_2 | 111 | 118 | PF00179 | 0.464 |
MOD_SUMO_rev_2 | 139 | 148 | PF00179 | 0.327 |
MOD_SUMO_rev_2 | 295 | 305 | PF00179 | 0.603 |
TRG_DiLeu_BaEn_1 | 304 | 309 | PF01217 | 0.488 |
TRG_ENDOCYTIC_2 | 201 | 204 | PF00928 | 0.461 |
TRG_ENDOCYTIC_2 | 227 | 230 | PF00928 | 0.535 |
TRG_ENDOCYTIC_2 | 306 | 309 | PF00928 | 0.520 |
TRG_ENDOCYTIC_2 | 66 | 69 | PF00928 | 0.417 |
TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.449 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0V1 | Leptomonas seymouri | 53% | 100% |
A0A0S4KDQ4 | Bodo saltans | 42% | 100% |
A0A1X0NQ77 | Trypanosomatidae | 44% | 99% |
A0A381MFS8 | Leishmania infantum | 51% | 100% |
A0A3Q8I9T1 | Leishmania donovani | 53% | 100% |
A0A3R7N2S2 | Trypanosoma rangeli | 42% | 97% |
A0A3S7WSX7 | Leishmania donovani | 51% | 100% |
C9ZT43 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 37% | 94% |
E9AGK8 | Leishmania infantum | 53% | 100% |
E9APN2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 52% | 100% |
E9APN3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 54% | 100% |
E9APN4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 51% | 100% |
Q4QFU5 | Leishmania major | 50% | 100% |
Q4QFU6 | Leishmania major | 51% | 100% |
V5BD72 | Trypanosoma cruzi | 42% | 97% |